Back to Article List

House of representatives investigates FDA action to regulate cannabidiol (CBD) products as dietary supplements


Apr 17, 2023

House Committee on Oversight and Accountability Chairman James Comer (R-Ky.) is investigating the Food and Drug Administration’s (FDA) failure to regulate cannabidiols (CBD) products as dietary supplements. In a letter to the Commissioner of Food and Drugs at the FDA, Dr. Robert M. Califf, Chairman Comer raises concern that the agency’s failure to regulate CBD products could allow dangerous products to come to market and is requesting documents and information to enable oversight of the FDA’s failure to provide Americans with regulatory guidance.


For further information (in English), click on the Link


Related Articles
See All News
Subscribe to our newsletter

The best industry insight in your mailbox